119 related articles for article (PubMed ID: 2689108)
1. [Current status of the treatment of acute lymphocytic leukemia in the adult].
Shi YD; Zhang ZN
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
[No Abstract] [Full Text] [Related]
2. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
3. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
[No Abstract] [Full Text] [Related]
4. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
[No Abstract] [Full Text] [Related]
5. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
[No Abstract] [Full Text] [Related]
6. Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
Abdalla A; Badrawy F; Khalifa A; Hamza R
Chemioterapia; 1987 Jun; 6(2 Suppl):743-4. PubMed ID: 3509537
[No Abstract] [Full Text] [Related]
7. Intensive therapy for adult acute lymphoblastic leukemia.
Berman E; Weiss M; Kempin S; Gee T; Bertino J; Clarkson B
Semin Hematol; 1991 Jul; 28(3 Suppl 4):72-5. PubMed ID: 1780756
[No Abstract] [Full Text] [Related]
8. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
Kuribara R; Muroi K; Yoshida M; Suzuki T; Izumi T; Hatake K; Amemiya Y; Miura Y
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1613-7. PubMed ID: 9725058
[No Abstract] [Full Text] [Related]
10. [L-asparaginase therapy against hybrid leukemia: a case report].
Mitani K; Kobayashi Y; Kawamura Y; Usuki K; Yuo A; Ishikawa F; Kitamura T; Ozawa K; Kitamura K; Urabe A
Rinsho Ketsueki; 1988 Sep; 29(9):1442-6. PubMed ID: 3216516
[No Abstract] [Full Text] [Related]
11. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
Rokicka-Milewska R; Derulska D; Lewicki Z
Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657
[No Abstract] [Full Text] [Related]
12. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
13. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
[No Abstract] [Full Text] [Related]
14. Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
Piccaluga PP; Malagola M; Rondoni M; Amabile M; Paolini S; Soverini S; Gaitani S; Visani G; Baccarani M; Martinelli G
Eur J Haematol; 2004 Apr; 72(4):302-3. PubMed ID: 15089772
[No Abstract] [Full Text] [Related]
15. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
Bancillon A
Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
[No Abstract] [Full Text] [Related]
16. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
17. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
18. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
[No Abstract] [Full Text] [Related]
19. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in acute lymphocytic leukemia (ALL).
Dicke KA; Spinolo JA
Leukemia; 1992; 6 Suppl 2():136-8. PubMed ID: 1578916
[No Abstract] [Full Text] [Related]
[Next] [New Search]